Tempus and LabCorp announce collaboration to accelerate clinical trial patient participation

CHICAGO & BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 16, 2020-- Tempus, a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare, and LabCorp (NYSE: LH), a leading global life sciences company, today announced a collaboration with LabCorp’s drug development business, Covance. LabCorp will participate in Tempus's TIME Trial® Network and the companies will work together to accelerate patient enrollment for oncology clinical trials through an innovative, data-driven approach that aims to transform the clinical trial model and modernize how they are designed and executed.

Labcorp acquires clinical ambulatory laboratory business of Franciscan Missionaries of Our Lady health system

LabCorp Expands Services in Louisiana and Mississippi Through Acquisition and Creation of a Comprehensive Clinical Laboratory Relationship

Labcorp launches first combined test for COVID-19, flu and RSV in time for flu season

Single Test Detects Multiple Respiratory Infections Including COVID-19 and Flu to Inform Treatment Options At-Home Use Through Pixel by Labcorp™   Pending FDA Authorization BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 8, 2020-- Labcorp (NYSE: LH), a leading global life sciences company that is deeply

LabCorp is scheduled to present at the Baird’s 2020 Global Healthcare conference

BURLINGTON, N.C. --(BUSINESS WIRE)--Sep. 1, 2020-- LabCorp (NYSE: LH) today announced that members of the executive management team will participate in a virtual fireside chat at the Baird’s 2020 Global Healthcare Conference on Wednesday, Sept. 9 at 11:25 a.m. ET.